ABEONA THERAPEUTICS INC. Variable Lease, Cost
ABEONA THERAPEUTICS INC. (ABEO) reported Variable Lease, Cost of $158.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. variable lease, cost for the quarter ending 2026-06-30 was $158.00K, a 100.00% increase year-over-year.
- ABEONA THERAPEUTICS INC. variable lease, cost for the quarter ending 2026-03-31 was $182.00K, a 56.90% increase year-over-year.
- ABEONA THERAPEUTICS INC. variable lease, cost for the quarter ending 2025-12-31 was $104.00K, a 18.18% increase year-over-year.
- ABEONA THERAPEUTICS INC. variable lease, cost for the quarter ending 2025-09-30 was $122.00K, a 27.08% increase year-over-year.
- ABEONA THERAPEUTICS INC. variable lease, cost for fiscal 2025 was $421.00K, a 10.79% increase from fiscal 2024.
- ABEONA THERAPEUTICS INC. variable lease, cost for fiscal 2024 was $380.00K, a 6.15% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. variable lease, cost for fiscal 2023 was $358.00K, a 17.51% decline from fiscal 2022.
- ABEONA THERAPEUTICS INC. variable lease, cost for fiscal 2022 was $434.00K, a 2.47% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $158.00K 10-Q · filed 2026-08-13 | $340.00K 10-Q · filed 2026-08-13 | $444.00K derived: sum of 3 quarters · filed 2026-08-13 | $566.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $182.00K 10-Q · filed 2026-05-13 | $286.00K derived: sum of 2 quarters · filed 2026-05-13 | $408.00K derived: sum of 3 quarters · filed 2026-05-13 | $487.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $226.00K derived: sum of 2 quarters · filed 2026-03-17 | $305.00K derived: sum of 3 quarters · filed 2026-08-13 | $421.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $122.00K 10-Q · filed 2025-11-12 | $201.00K derived: sum of 2 quarters · filed 2026-08-13 | $317.00K 10-Q · filed 2025-11-12 | $405.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $79.00K 10-Q · filed 2026-08-13 | $195.00K 10-Q · filed 2026-08-13 | $283.00K derived: sum of 3 quarters · filed 2026-08-13 | $379.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $116.00K 10-Q · filed 2026-05-13 | $204.00K derived: sum of 2 quarters · filed 2026-05-13 | $300.00K derived: sum of 3 quarters · filed 2026-05-13 | $422.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $184.00K derived: sum of 2 quarters · filed 2026-03-17 | $306.00K derived: sum of 3 quarters · filed 2026-03-17 | $380.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $96.00K 10-Q · filed 2025-11-12 | $218.00K derived: sum of 2 quarters · filed 2025-11-12 | $292.00K 10-Q · filed 2025-11-12 | $369.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $122.00K 10-Q · filed 2025-08-14 | $196.00K 10-Q · filed 2025-08-14 | $273.00K derived: sum of 3 quarters · filed 2025-08-14 | $339.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $74.00K 10-Q · filed 2025-05-15 | $151.00K derived: sum of 2 quarters · filed 2025-05-15 | $217.00K derived: sum of 3 quarters · filed 2025-05-15 | $333.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $143.00K derived: sum of 2 quarters · filed 2025-03-20 | $259.00K derived: sum of 3 quarters · filed 2025-03-20 | $358.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $66.00K 10-Q · filed 2024-11-14 | $182.00K derived: sum of 2 quarters · filed 2024-11-14 | $281.00K 10-Q · filed 2024-11-14 | $289.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $116.00K 10-Q · filed 2024-08-12 | $215.00K 10-Q · filed 2024-08-12 | $223.00K derived: sum of 3 quarters · filed 2024-08-12 | $377.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $39.00K 10-Q · filed 2024-05-15 | $107.00K derived: sum of 2 quarters · filed 2024-05-15 | $261.00K derived: sum of 3 quarters · filed 2024-05-15 | $377.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $222.00K derived: sum of 2 quarters · filed 2024-03-18 | $338.00K derived: sum of 3 quarters · filed 2024-03-18 | $434.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $154.00K 10-Q · filed 2023-11-13 | $270.00K derived: sum of 2 quarters · filed 2023-11-13 | $366.00K 10-Q · filed 2023-11-13 | $467.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $116.00K 10-Q · filed 2023-08-08 | $212.00K 10-Q · filed 2023-08-08 | $313.00K derived: sum of 3 quarters · filed 2023-08-08 | $418.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $96.00K 10-Q · filed 2023-05-11 | $197.00K derived: sum of 2 quarters · filed 2023-05-11 | $302.00K derived: sum of 3 quarters · filed 2023-05-11 | $406.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $206.00K derived: sum of 2 quarters · filed 2023-03-29 | $310.00K derived: sum of 3 quarters · filed 2023-03-29 | $445.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $105.00K 10-Q · filed 2022-11-14 | $209.00K derived: sum of 2 quarters · filed 2022-11-14 | $344.00K 10-Q · filed 2022-11-14 | $425.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $104.00K 10-Q · filed 2022-08-11 | $239.00K 10-Q · filed 2022-08-11 | $320.00K derived: sum of 3 quarters · filed 2022-08-11 | $401.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $135.00K 10-Q · filed 2022-05-13 | $216.00K derived: sum of 2 quarters · filed 2022-05-13 | $297.00K derived: sum of 3 quarters · filed 2022-05-13 | $389.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $162.00K derived: sum of 2 quarters · filed 2022-03-31 | $254.00K derived: sum of 3 quarters · filed 2022-03-31 | $337.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $81.00K 10-Q · filed 2021-11-15 | $173.00K derived: sum of 2 quarters · filed 2021-11-15 | $256.00K 10-Q · filed 2021-11-15 | $337.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $92.00K 10-Q · filed 2021-07-28 | $175.00K 10-Q · filed 2021-07-28 | $256.00K derived: sum of 3 quarters · filed 2021-07-28 | $338.00K derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | $83.00K 10-Q · filed 2021-05-17 | $164.00K derived: sum of 2 quarters · filed 2021-05-17 | $246.00K derived: sum of 3 quarters · filed 2021-05-17 | $332.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $163.00K derived: sum of 2 quarters · filed 2021-03-24 | $249.00K derived: sum of 3 quarters · filed 2021-03-24 | $322.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $82.00K 10-Q · filed 2020-11-09 | $168.00K derived: sum of 2 quarters · filed 2020-11-09 | $241.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $86.00K 10-Q · filed 2020-08-10 | $159.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $73.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |